FXII Frameshift Variant Does Not Cause Hereditary Angioedema with Normal C1 Inhibitor
Journal of Clinical Immunology · 01.06.2026 · 46 (1)
DOI: 10.1007/s10875-026-02041-x ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Clinical Immunology, online erschienen am 01.06.2026. Verfasst von Toshiyuki Miyata und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan. Die Arbeit nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.
- Department of Biomedical Engineering, Osaka Institute of Technology, Osaka, Japan.
- Fukuoka City Hospital, Fukuoka, Japan.
- Center for Research, Education, and Treatment of AngioEdema, A Specified Non- profit Corporation, Fukuoka, Japan.
- Diagnostic Consortium to Advance the Ecosystem for Hereditary Angioedema (DISCOVERY), Saitama, Japan.
- Diagnostic Consortium to Advance the Ecosystem for Hereditary Angioedema (DISCOVERY), Saitama, Japan. ed1h-w1de-road@hiroshima-u.ac.jp.
Zitieren
APA
Miyata, T., Horiuchi, T., & Hide, M. (2026). FXII Frameshift Variant Does Not Cause Hereditary Angioedema with Normal C1 Inhibitor. Journal of Clinical Immunology, 46(1). https://doi.org/10.1007/s10875-026-02041-x
Vancouver
Miyata T, Horiuchi T, Hide M. FXII Frameshift Variant Does Not Cause Hereditary Angioedema with Normal C1 Inhibitor. Journal of Clinical Immunology. 2026;46(1). doi:10.1007/s10875-026-02041-x
BibTeX
@article{Miyata2026,
author = {Miyata, Toshiyuki and Horiuchi, Takahiko and Hide, Michihiro},
title = {FXII Frameshift Variant Does Not Cause Hereditary Angioedema with Normal C1 Inhibitor},
journal = {Journal of Clinical Immunology},
year = {2026},
volume = {46},
number = {1},
doi = {10.1007/s10875-026-02041-x}
}
EUVIMED